coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    The Ridge PCN, Maidstone · Health Inequalities Profile

    PCN U13761 · NHS Kent and Medway Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    36,913

    Registered population

    55.6% aged 18–64

    24.5%

    Aged 65+

    ICB 19.9% · England 17.9%

    6.0%

    Ethnic minority (non-White)

    2.2% Asian · England 9.6%

    0.5%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~182

    Core20 residents (est.)

    Resident basis; registered basis ~240 · see page 3

    6,437

    Hypertension register

    +7.44% in 3 yrs · England +5.60%

    237

    SMI register

    14% of Maidstone's

    572

    COPD register

    Reviews +15.06% in 3 yrs

    Forecast to 2030

    7,723

    Hypertension patients, 2030

    +1,286 on today

    78.8%

    QRISK ≥20% on statins, 2030

    +9.04pp over 3 yrs

    6.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    65.0%
    Hypertension control lags despite high BP recording.

    Treatment to target is 65.0% (England 70.3%) after a -5.2% 3-year change, while QRISK ≥ 20% lipid therapy is 55.0% (England 63.6%).

    11.4 pp
    Age-five booster uptake trails first MMR dose.

    At age 5, MMR1 reaches 95.5%, but MMR2 is 84.1% (an 11.4 pp difference) and the 4-in-1 booster is 80.7% against the 95.0% target.

    89.4%
    Diabetes glycaemic control exceeds national and ICB averages.

    HbA1c control reaches 89.4% in patients with frailty (England 81.9%) and 62.2% without frailty (England 57.4%), alongside 86.2% SMI blood pressure checks.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    An older population profile with 24.5% aged 65+ may drive higher frailty needs

    THE RIDGE PCN has 36,913 registered patients. Patients aged 65+ make up 24.5% (9,044), above Maidstone (18.7%), NHS Kent and Medway ICB (19.9%) and England (17.9%). Adults aged 18–64 comprise 55.6% (20,537), below Maidstone (59.8%), ICB (59.5%) and England (62.7%). Those aged 0–17 comprise 19.9% (7,332). In associated Census areas, 94.0% are White (Maidstone 89.8%, ICB 88.6%, England 81.1%), and 6.0% are ethnic minorities. Projected population growth to 2030 is 3.1% via unverified methodology. Ethnicity reflects Census residents, not GP registrations.

    Age profile

    0–1719.9%
    18–6455.6%
    65+24.5%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White94.0%
    Asian2.2%
    Mixed1.8%
    Black1.4%
    Other0.7%

    Older people · falls rows are Maidstone local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Maidstone LA)2,6532,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)89.4%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)62.2%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Maidstone LA)1,3809819552024/25
    Falls deaths, all ages, per 100,000 (Maidstone LA)15.814.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 0.5% network-wide and concentrated entirely in Langley at 7.0%

    The PCN records an average IMD decile of 6.4 (Maidstone 5.9, ICB 5.4, England 5.5). Core20 share is 0.5%, below Maidstone (9.9%), the ICB (17.1%), and England (21.0%). Deprivation is concentrated at Langley (7.0% share; 240 estimated patients), while Bearsted, Len Valley Practice, and Sutton Valence Group Practice record 0.0%. Registered estimates (240 patients; weighted share 0.7%) diverge from 182 residents across 1 decile-2 LSOA. Targeted inequalities outreach will achieve greatest reach by prioritising Langley, the practice with Core20 registered patients.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Langley7.0% · 240 patients
    Bearsted0.0% · 0 patients
    Len Valley0.0% · 0 patients
    Sutton Valence0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    237

    SMI register

    0.64% recorded prevalence

    227

    Learning disability register

    0.62% recorded prevalence

    16

    Care homes, 780 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Maidstone, Census 2021

    Learning disability prevalence is 0.6% (227 patients, matching England) and severe mental illness is 0.6% (237 patients, below England at 1.0%). The catchment holds 16 care homes (780 beds), with 0.8% Gypsy or Irish Traveller residents (England 0.1%). Applying the borough rate yields a modelled ceiling estimate of 3,211 unpaid carers.

    Severe mental illness: physical health checks

    Recorded SMI prevalence is 0.6% (England 1.0%). Blood pressure checks reached 86.2% (England 83.4%) and BMI recording was 83.2% (England 82.1%). Bearsted recorded 79.1% for blood pressure checks and 74.6% for BMI. Other check elements were not captured.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,437

    Hypertension register

    +7.44%

    Register growth, 3 yrs

    Maidstone +4.31% · England +5.60%

    −1.17pp

    BP control, under 80

    ≤140/90 · −2.50pp aged 80+

    +1,286

    More patients by 2030

    Forecast 7,723 (20.14%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 17.4% (6,437 patients), above England (15.2%), Maidstone (16.0%) and NHS Kent and Medway ICB (16.2%). Recent blood pressure checks reached 88.8% (Maidstone 90.4%, England 90.0%). Patients treated to target stands at 65.0% (England 70.3%, Maidstone 69.7%, NHS Kent and Medway ICB 67.7%), following a 3-year change of -5.2% (England +3.6%). Blood pressure control under age 80 is 63.7% (England 67.8%), dropping to 61.1% at Bearsted, while control aged 80+ is 76.7% (England 81.2%). Treatment to target trails national benchmarks across both age cohorts, suggesting medication titration and structured recall could be evaluated to narrow the gap.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid-lowering therapy uptake is 55.0%, below England (63.6%), Maidstone (60.3%) and NHS Kent and Medway ICB (61.4%). Statin therapy for diabetes with history of CVD is 81.0% (England 84.4%, Maidstone 83.3%, NHS Kent and Medway ICB 83.3%).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202684,053£1.20£1.90£1.86£100,864
    Cardiovascular (all), 2025114,397£2.30£3.57£3.33£263,113

    In 2026, the PCN prescribed 84,053 items for lipid-regulating drugs at £1.20 per item, below England (£1.86), Maidstone (£1.62) and NHS Kent and Medway ICB (£1.90). Spend was £55,475 less than at England's unit cost across those items.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +20.72%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.33%

    Asthma prevalence, PCN 3-yr % change

    Asthma reviews reached 69.5% (England 65.7%, Maidstone 63.2%) with a 3-year change of +20.7% (England +4.4%), leaving 666 patients on the 2,185 register without a recorded review. Asthma prescribing for ages 5–19 is 1,484 items per 1,000 (Maidstone 1,220), while second-hand smoking status recording is 75.0% (England 78.8%). COPD prevalence is 1.6% (572 patients; England 1.9%) with reviews at 75.9% and a 3-year change of +15.1% (England +2.8%). An unadjusted model suggests a benchmark register gap of +68 to +127 patients.

    Cancer register and children's immunisation

    Cancer prevalence is 5.2% (1,931 patients; England 3.8%, Maidstone 4.3%). In Q1 2025/26, MMR dose 1 coverage at age 5 reached 95.5% (0.5 pp above the 95.0% target), but MMR dose 2 was 84.1% (10.9 pp below target), an 11.4 pp difference between doses in the cohort. The 4-in-1 pre-school booster reached 80.7% (14.3 pp below target).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months90.7%

    England 91.0%

    6-in-1 complete primary course at 24 months94.4%

    England 92.2%

    MMR dose 1 at 24 months93.0%

    England 88.3%

    MMR dose 2 at age 584.1%

    England 82.8%

    4-in-1 pre-school booster at age 580.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In 2022, 55.6% of cancers with a known stage in NHS Kent and Medway ICB were diagnosed at stage 1 or 2 (4,661 of 8,384), in line with England (55.3%) but 19.4 pp below the 75.0% national ambition by 2028. Staging was recorded for 63.6% of registered cancers (8,384 of 13,189; England 67.0%), requiring 1,627 extra early diagnoses across the ICB to achieve 75%. Staging data is ICB-level rather than PCN performance, and small numbers limit site comparisons. PCN cancer prevalence is 5.2% (1,931 patients; England 3.8%). Cervical screening is 75.3% (England 66.8%), though Sutton Valence Group Practice is lower at 67.8%.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026, Maidstone and Tunbridge Wells NHS Trust met all three cancer standards: 87.4% on 62-day referral to treatment (standard 85.0%), 81.8% on 28-day faster diagnosis (standard 75.0%), and 98.3% on 31-day combined treatment (standard 96.0%). Across NHS Kent and Medway Integrated Care Board, 62-day compliance was 75.9% (England 71.2%), while Medway NHS Foundation Trust achieved 81.6% and East Kent Hospitals University NHS Foundation Trust reached 70.0%. For diagnostic waits over 6 weeks, Maidstone and Tunbridge Wells NHS Trust recorded 0.9% for MRI and 0.5% for CT, but 19.8% for colonoscopy (England 30.8%).

    Pathways within standard (%)Maidstone and Tunbridge WellsMedwayEast KentKent and Medway ICBEngland
    28-day faster diagnosis (75%)81.7877.7771.2876.7879.32
    31-day treatment (96%)98.3599.6296.6795.8492.50
    62-day referral to treatment (85%)87.4381.6470.0175.9371.16
    Diagnostic waits over 6 weeks (%)Maidstone and Tunbridge WellsMedwayEast KentEngland
    MRI0.920.6847.5821.40
    CT0.510.0037.459.92
    Echocardiography2.5736.6214.1728.48
    Colonoscopy19.801.889.5830.83
    Gastroscopy24.033.3222.1629.02
    All 15 DM01 tests6.4214.2048.3823.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In Jun 2026, 65.8% of community health service contacts for Maidstone borough residents were with adults aged 65 and over (138,250 of 210,170 contacts). With 24.5% of THE RIDGE PCN's registered population aged 65+ (9,044 patients; England 17.9%), local community services may face substantial demand from older patients requiring ongoing supportive care, although activity is published at borough rather than PCN level.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans a 65.1 pp spread across the PCN's four practices

    In 2025/26, overall QOF achievement ranged from 68.5% at Sutton Valence Group Practice and 83.3% at Len Valley Practice to 94.5% at Bearsted and 99.0% at Langley (England 92.5%). Vaccination achievement spanned 75.4 pp, from 15.6% at Sutton Valence Group Practice to 91.0% at Langley. Practice audits could test whether recall or recording differences explain these variations.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Langley1157.096.5%79.2%97.6%
    Bearsted1050.066.2%68.4%87.8%
    Sutton Valence1150.058.6%62.4%79.5%
    Len Valley1010.031.4%80.1%60.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNMaidstoneAssetPCNMaidstone
    Care homes (catchment)16 (780 beds)n/aSchools (catchment)40n/a
    Children's centresno data7Places of worship4094
    Libraries39Food banks (VCS)n/a1
    Homelessness support (VCS)n/a1Day centres (VCS)n/a3
    Children and young people (VCS)13Carers support groups (VCS)14
    Primary schools (LA maintained)1328Primary academies414

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension and lipid escalation review

    On the 6,437 hypertension register (17.4%), 65.0% are treated to target (England 70.3%, Maidstone 69.7%) after a -5.2% 3-year change (England +3.6%); QRISK ≥ 20% lipid therapy is 55.0% (England 63.6%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Pre-school booster and MMR2 recall

    In Q1 2025/26 (cohort 88), age-5 MMR2 is 84.1% (11.4 pp below MMR1 at 95.5%; 10.9 pp below the 95.0% target) and 4-in-1 booster coverage is 80.7% (14.3 pp below target). For discussion: practices could validate age-5 cohorts and run flexible pre-school catch-up reminders for second-dose MMR and 4-in-1 boosters. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    COPD and heart failure case-finding

    COPD prevalence is 1.6% (572 patients vs Maidstone 1.7%, England 1.9%; unadjusted gap +68 to +127) and heart failure is 0.8% (293 vs 0.9% and 1.1%; gap +44 to +112). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older population anticipatory care (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall audit (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Cardiovascular treatment titration review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall review (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026Practice
    Telephony and triage operational review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Hypertension and lipid escalation review (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Pre-school booster and MMR2 recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · COPD and heart failure case-finding (p12)COPD register · COPD: QOF prevalence · Heart failure registerCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15